In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Thermo Fisher in $15.2bn takeover of Life Technologies

Executive Summary

After weeks of rumors, Thermo Fisher Scientific Inc. has finally publicly disclosed a definitive deal to acquire Life Technologies Corp. for $76 in cash per share (a 42% premium to the ten days prior to Life Tech’s announcement that it was conducting a strategic review), valuing the public life sciences company at $15.2bn, including $2.2bn in assumed net debt. The transaction is the largest M&A ever in the research field, surpassing Thermo Electron’s $11.8bn merger with Fisher Scientific in 2006.
Deal Industry
  • Research, Analytical Equipment & Supplies
  • Services
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies